Latest news
Biomarkers aid cost-benefit analysis of head and neck cancer immunotherapy - medicalxpress.commedicalxpress.com · Mon, 10 Aug 2026 17:00:04 GMTA Tumor of Intrigue: Undifferentiated Carcinoma With Osteoclastic Giant Cells of the Urinary Bladder - CureusCureus · Mon, 10 Aug 2026 11:16:57 GMTMetastatic Renal Cell Carcinoma in 2026: Frontline Combinations, Post-IO Sequencing, and the Emergence of HIF-2α Inhibition - OncodailyOncodaily · Fri, 07 Aug 2026 14:44:09 GMTAdvanced Renal Cell Carcinoma: Applying Sequencing Principles in Clinical Practice - Targeted OncologyTargeted Oncology · Thu, 06 Aug 2026 12:16:28 GMTAdvanced Renal Cell Carcinoma: Interpreting Emerging Evidence for Belzutifan-Based Therapies - Targeted OncologyTargeted Oncology · Thu, 06 Aug 2026 12:05:08 GMTSynchronous Clear Cell and Papillary Renal Cell Carcinoma Collision Tumor Confirmed by Component-Specific Next-Generation Sequencing: A Case Report - CureusCureus · Sat, 01 Aug 2026 06:55:07 GMTOncology Pulsepoint: How Updated Immunotherapy Guidelines are Changing Renal Cell Carcinoma Care - Pharmacy TimesPharmacy Times · Wed, 29 Jul 2026 07:00:00 GMT